Passage bio inc.

Medical-Specialities

PASG


Executive/
Director

Price

  • Last Close
  • $ 0.82
    $ -0.01 -1.32 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.73 - $0.6
  • YTD
  • 34.4%

  • Trading Volume
  • 12,490
  • Market Cap Full
  • $ 45M
  • Shares Outstanding
  • 54.8M
    Nov 8, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -31.6% -51.2% -30.6% 37.6% 34.4%
Q2 - - - - 4% -24.3% -23.9% -1.8% -33.8% -
Q3 - - - - 8% -24.8% -47% -30.1% -19.5% -
Q4 - - - - 95% -36.2% 10.4% 53.3% -23.8% -
J F M A M J J A S O N D
2025 34.4% - - - - - - - - - - -
2024 -3% 74.5% -18.7% -15.8% -6% -18.1% 2.7% -19.5% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-75%-78%-27%-40%34%

Earnings

2020 2021 2022 2023
Q1 - -0.76 -0.79 -0.63
Q2 - -0.9 -0.73 -0.44
Q3 - -0.87 -0.49 -0.49
Q4 - -0.95 -0.49 -
A -2.9 -3.5 -2.5 -1.56

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 53.8 54.3 54.6
Jun 45.4 54 54.3 54.6
Sep 45.5 54.1 54.5 54.8
Dec 45.5 54.1 54.6 54.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 69 186 113 -4.1 -
Equity multiplier 0.1 0.1 - -0.2 -